Back to Search
BRIAN TSENG, MD, PHD
MD, PHD
Neurology with Special Qualifications in Child Neurology Physician
NPI: 1134204878Individual
Specialties, Licenses & Credentials
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
233672(MA)A73767(CA)
Research & Publications (20)
Discovery of substituted 4-anilino-2-arylpyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 2. Structure-activity relationships of the 2-aryl group.
PMID 19285392·Bioorg Med Chem Lett·2009
4-observational
Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay.
PMID 19369076·Bioorg Med Chem Lett·2009
8-other
Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
PMID 19282188·Bioorg Med Chem·2009
8-other
Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers.
PMID 19464890·Bioorg Med Chem Lett·2009
8-other
Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
PMID 19467598·Bioorg Med Chem Lett·2009
8-other
Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration.
PMID 19296653·J Med Chem·2009
7-preclinical
Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.
PMID 19500976·Bioorg Med Chem Lett·2009
7-preclinical
Real-time polarization mode dispersion monitoring system for a multiple-erbium-doped fiber amplifier, dense wavelength division multiplexing optical fiber transmission by amplified spontaneous emission modulation and acousto-optic tunable fiber scanning techniques.
PMID 19252622·Appl Opt·2009
8-other
Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts.
PMID 19487307·FASEB J·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, ACC 708
BOSTON, MA 02114 - Phone
- (617) 840-0528
Quick Facts
- NPI
- 1134204878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile